Last edition
News about "Sun Pharma settles Leqselvi litigation with Incyte"
Sun Pharma, Incyte Reach Settlement and License Agreement Over Leqselvi Manufacturing Rights
As part of the agreement, both parties will jointly move to dismiss the litigation pending in the United States District Court for the District of New Jersey. They have also agreed to mutually release all current and potential claims related to the case.
Sun Pharma Settles Leqselvi Litigation With Incyte | 14/07/2025 | By Darshana | 103
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members